| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.6B | $16.1B | $13.7B | $17.5B | $14.3B | $3.8B | $4.0B | $3.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.2B | $1.6B | $0.6B | $4.8B | $1.7B | $0.5B | $0.3B | $0.2B |
| EPS (Basic) | $5.32 | $6.77 | $2.58 | $19.16 | $6.36 | $1.72 | $1.08 | $0.84 |
| EPS (Diluted) | $5.25 | $6.68 | $2.55 | $18.85 | $6.27 | $1.70 | $1.07 | $0.83 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $341.4B | $313.7B | $305.0B | $292.2B | $304.7B | $296.6B | $276.1B | $243.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $4.4B | $4.2B | $4.7B | $4.8B | $2.3B | $2.8B | $2.5B | $3.0B |
| Total Liabilities | $329.0B | $302.2B | $293.8B | $281.9B | $288.2B | $279.8B | $261.1B | $231.2B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $11.9B | $11.1B | $10.9B | $10.0B | $16.1B | $16.6B | $14.6B | $11.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.5B | $4.6B | $3.8B | $3.2B | $3.2B | $3.7B | $5.5B | $5.2B |
| Investing Cash Flow | $-4.1B | $-5.4B | $-1.3B | $1.1B | $-5.7B | $-5.0B | $-7.7B | $-5.7B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.2B | $0.3B | $-2.6B | $-1.7B | $1.9B | $1.6B | $1.7B | $1.1B |